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158 AKT1 CONTRIBUTES TO CHONDROCYTE CALCIFICATION
DURING ENDOCHONDRAL OSSIFICATION
A. Fukai, N. Kawamura, K. Nakamura, U.I. Chung, H. Kawaguchi. The
University of Tokyo, Tokyo, JAPAN
Purpose: Endochondral ossiﬁcation plays crucial roles in skeletal dis-
orders like osteoarthritis as well as in skeletal growth. Since the
phosphoinositide-dependent serine-threonine protein kinase Akt has
been proposed to be a pivotal signaling molecule for several factors regu-
lating cartilage metabolism, this study examined the possible involvement
of Akt in the processes of endochondral ossiﬁcation.
Methods: Expressions of the three isoforms of Akt (Akt1, 2 & 3) were
examined by real-time RT-PCR in chondrocytes derived from ribs of
neonatal mice. To know the physiological function of Akt1, we compared
the skeletal phenotypes of homozygous Akt1-deﬁcient (Akt1−/−) mice
with those of the wild-type littermates by plain radiograph, 3D-mCT, and
histological analyses including toluidine blue, von Kossa stainings, type X
collagen (COL10) immunostaining, and BrdU labeling. For gain- and loss-
of-function analyses, we established stable lines of mouse chondrogenic
ATDC5 cells with retroviral overexpression of constitutively active Akt1
(CA-Akt1) and small interfering RNA (siRNA) of Akt1, respectively, and
compared the functions with respective empty-vector controls. Cell pro-
liferation was assessed by CCK-8 assay. The differentiation was deter-
mined by Alcian blue and alkaline phosphatase (ALP) stainings under the
stimulation of insulin. The hypertrophic differentiation was determined by
luciferase assays using ATDC5 cells transfected with a luciferase-reporter
gene construct containing a 4.5-kb fragment of the COL10 promoter.
Calciﬁcation was assessed by Alizarin red staining under the stimulation
of insulin and inorganic phosphate ion (Pi). Expressions of inorganic
pyrophosphate (PPi)-related factors were determined by semi-quantitative
RT-PCR.
Results: Since Akt1 was most highly expressed in chondrocytes among
the three isoforms, we generated Akt1−/− mice and examined the skeletal
phenotype. The Akt1−/− mice exhibited dwarﬁsm with about 20% shorter
limbs and trunks than the wild-type littermates during observation periods
from embryos to 12 weeks postnatal. The entire width and columnar
structure of the growth plate cartilage were normal, and BrdU-positive
proliferative zone and COL10-positive hypertrophic zones were also
unaffected by the Akt1 deﬁciency. However, the width of the calciﬁed
layer and the number of calciﬁed chondrocytes determined by the von
Kossa staining were signiﬁcantly decreased at the bottom of the Akt1−/−
growth plate. In the ATDC5 cell culture, neither the CA-Akt1 nor the
Akt1 siRNA overexpression altered cell proliferation, differentiation, or the
COL10 promoter activity. Contrarily, calciﬁcation of ATDC5 cells cultured
in the presence of insulin/Pi was signiﬁcantly enhanced by the CA-Akt1
and suppressed by the Akt1 si-RNA. These in vivo and in vitro ﬁndings
demonstrate that Akt1 is essential for chondrocyte calciﬁcation without
affecting the prior processes of endochondral ossiﬁcation. As PPi has
been known to be a crucial regulator of chondrocyte calciﬁcation, we
ﬁnally examined expressions of principal modulators of PPi: ANK, NPP1
and Pit1. Although all increased during chondrocyte calciﬁcation under
the insulin/Pi stimulation, none of them was affected by the CA-Akt1 or
the Akt1 si-RNA.
Conclusions: Akt1 controls skeletal growth by maintaining chondrocyte
calciﬁcation during endochondral ossiﬁcation, without affecting the pro-
liferation or differentiation of chondrocytes. Further understanding of the
molecular network related to Akt1, probably independent of the putative
PPi pathway, will quite probably lead to a breakthrough for the treatment
of skeletal disorders like osteoarthritis.
159 ECM REMODELLING PLAYS A CRUCIAL ROLE IN THE LOSS
OF MATURATIONAL ARREST OF OA CHONDROCYTES
R. Borzı`1, E. Olivotto1, S. Pagani1, S. Neri1, M. Battistelli2, E. Falcieri2,
A. Facchini3, F. Flamigni3, A. Facchini4, K.B. Marcu5. 1Istituti Ortopedici
Rizzoli, Bologna, ITALY , 2Istituto di Scienze Morfologiche, Universita`
degli Studi di Urbino, Urbino, ITALY, 3Dipartimento di Biochimica,
Universita` degli Studi, Bologna, ITALY, 4Dipartimento di Medicina Clinica,
Universita` degli Studi, Bologna, ITALY, 5Department of Biochemistry and
Cell Biology Stony Brook University, Stony Brook, NY, USA
Purpose: IKKa, one of the two NF-úB activating kinases, has as yet
unknown roles in cartilage pathophysiology. Our previous work revealed
an unexpected role of IKKa in ECM remodelling and progression to hyper-
trophy and terminal differentiation of primary osteoarthritic chondrocytes,
with a “chondrogenic” and abundant ECM being a key feature of cells
lacking IKKa. Here we have begun to mechanistically deﬁne how IKKa
affects the terminal chondrogenic differentiation program.
Methods: Primary chondrocytes were derived from 14 Osteoarthritis
(OA) patients undergoing joint arthroplasty. Stable and efﬁcient expres-
sion of IKKa or IKKb or MMP-13 shRNAs was achieved by transduction
with a pSUPER retroviral vector and populations of shRNA expressing
cells were selected for puromycin resistance. Knock-down (KD) efﬁcien-
cies were determined as follows: by Western blotting for each IKK in
comparison to cells transduced by a ﬁreﬂy luciferase shRNA retrovector;
and by ELISA for MMP-13 released by Il-1b stimulation of monolayer or
micromasses established from MMP-13 KD or control chondrocytes.
High density monolayer and micromass cultures (1, 2 and 3 weeks)
in mineralizing conditions were selected to investigate the effects of
either IKK or MMP-13 KD on key regulators of chondrogenesis (including
SOX-9, Runx-2 and b-catenin), and of angiogenesis (VEGF) at the protein
(immunohistochemistry or western blot) and RNA (real time PCR) levels.
The viability and subcellular features of micromass chondrocytes were
also evaluated to assess their progression to terminal differentiation. ECM
turnover was assessed by comparison of the C1,2C and TIMP staining
of micromasses evaluated by immunohistochemistry.
Results: MMP-13 KD was found to mimick the effects of IKKa KD in the
control of the chondrogenic program, as recapitulated in micromass cul-
tures. Thus loss of either IKKa or MMP-13 suppressed the accumulations
of SOX-9, Runx-2 and VEGF (at the protein and RNA levels) contributing
to the maturational arrest of articular chondrocytes. On the other hand,
in control micromasses, the chondrogenic program progressed up to the
calcium deposition stage in conjunction with reduced cell viability, scant
ECM and a paucity of specialized cell-cell and cell-ECM junctions. IKKa,
IKKb and MMP-13 KD cells also displayed a lower C1,2C staining at
1 week, compared to control micromasses. Noteworthy IKKa KD cells
were markedly and reproducibly characterized by a high level of TIMP-3
staining in 1 week micromasses, while TIMP-1 and TIMP-4 levels were
elevated in some but not in all IKKa samples derived from different OA
patients.
Conclusions: Since micromasses established with IKKa and MMP-13
(the key collagenolitic enzyme in OA) KD chondrocytes, presented com-
parable phenotypes, our data reveal that ECM remodelling has a crucial
role in the capacity of OA chondrocytes to progress towards terminal dif-
ferentiation. Moreover, our observations also suggest that IKKa functions
at least in part as a positive effector of ECM remodelling by suppressing
TIMP-3 (given the unique attributes of TIMP-3 to control MMPs, as well
as ADAMTS-4, 5 and 17), thereby allowing for progression to hypertrophy
in Osteoarthritis and possibly also in normal bone development.
160 PTH ACTS AS AN ANABOLIC EFFECTOR ON
OSTEOARTHRITIC ARTICULAR CARTILAGE: COULD PTH BE
A NEW TREATMENT OPPORTUNITY FOR OSTEOARTHRITIS?
B-C. Sondergaard1, S.H. Madsen1, A.-C. Bay-Jensen1, N. Sims2,
J.H. Gooi2, M.A. Karsdal1. 1Nordic Bioscience, Herlev, DENMARK, 2St.
Vincent’s Institute, Fitzroy, AUSTRALIA
Purpose: In view of the fact that pathogenesis of osteoarthritis (OA)
involves both the bone and cartilage compartments of the affected joints,
an increasing amount of attention is directed to potential treatments of
OA with positive effect on calcium metabolism. One of the factors that
are known to have an anabolic effect on bone is parathyroid hormone
(PTH). However, in vivo effects of PTH on cartilage has until now been an
open question. In bone, PTH acts on osteoblasts, initiating the G-coupled
receptor pathway through cAMP. Interestingly, cAMP has recently been
shown to be of major importance for the chondrocyte phenotype. Since
chondrocytes and osteoblasts originate from the same mesenchymal
lineage, we hypothesize that chondrocytes and osteoblasts, respond an-
abolically similar to PTH treatment. Thus, PTH could potentially represent
a novel treatment opportunity for OA. To test this hypothesis, we used
validated human OA cartilage in vitro models and a pre-clinical model of
accelerated cartilage loss in vivo for our investigations.
Methods: In vitro: Human chondrocytes were isolated and maintained
serum-free for 1 hour in the presence of 100 mM IBMX (PDE inhibitor), and
subsequently stimulated with PTH 1nM-100 nM + IBMX and the cAMP
levels were quantiﬁed by ELISA. In addition, articular cartilage explants
were cultured in 6 replicates for 17 days, with or without 10 nM PTH
treatment, and 5mCi 35sulphate was added for the last 24 hours. Soluble
proteoglycans were released by 4M GuHCl and incorporated sulphate
was measured. Neo-epitopes of pro-peptides of collagen type II (PIINP)
were quantiﬁed as a measure of formation in the conditioned medium.
In vivo: Thirty 5-month old female rats were subjected to either sham
S82 Osteoarthritis and Cartilage Vol. 16 Supplement 4
or ovariectomy (OVX), and administered either vehicle or 30 mg/kg hPTH
(1−34aa) by s.c. injection for 5 weeks, n = 10. Serum levels of osteocalcin
and CTX-II were measured by speciﬁc ELISAs.
Results: When stimulated with PTH, the cultured chondrocytes accumu-
lated intracellular cAMP levels signiﬁcantly (P< 0.003) in a dose-depend
manner. The maximum concentration of PTH (100 nM) resulted in a 23-
fold increase compared with vehicle control. In the explants cultures of
OA articular cartilage, a two-fold increase of PIINP was observed in
the supernatant after PTH stimulation when compared to non-stimulated
cartilage samples. Furthermore, 10 nM PTH increased incorporation of
35sulphate by 40% (p=0.002). The serum level of the bone turnover
marker osteocalcin was signiﬁcantly (p< 0.001) elevated in OVX animals
that were PTH treated compared to sham and vehicle treated, while the
level of serum cartilage degradation marker CTX-II decreased by 30%
(p< 0.01).
Conclusions: The current data strongly suggest that PTH, in addition
to osteoblasts and bone turnover, also has direct anabolic effects on
chondrocytes and cartilage. We have shown that PTH can not only
avert but also facilitate cartilage generation in both in vitro and in vivo
situations. Presented data indicate the potency of PTH and intrigues
further investigation of PTH as a potential DMOAD.
161 NMDA RECEPTOR FUNCTION IN OSTEOARTHRITIC
CHONDROCYTES IS DEPENDENT ON b1 INTEGRINS
L. Ramage, G.E. Hardingham, D.M. Salter. The University of Edinburgh,
Edinburgh, UNITED KINGDOM
Purpose: Osteoarthritis (OA) is associated with abnormal loading of
articular joints. In normal joints physiological loading maintains structure
and function of cartilage and chondrocytes within. This is mediated
by a process known as mechanotransduction whereby the mechanical
forces are recognized by the resident chondrocytes and transduced into
biochemical and molecular responses. In chondrocytes a5b1 integrin
is a major mechanoreceptor and activation triggers signaling events
and autocrine/paracrine signaling via IL4 which lead to up-regulation of
anabolic genes and down-regulation of catabolic activity. In OA however
this mechanism is disrupted and mechanically stimulate chondrocytes
express pro-inﬂammatory and catabolic IL1b. The reasons for this are
unclear but recent research from our group has raised the possibility that
differential involvement of ionotropic glutamate receptors, NMDARs in the
mechanotransduction pathway may be important. NMDARs are associ-
ated with neurons, although non-neuronal tissues have been shown to
express these receptors. In neurons, NMDAR interact with intracellular
signaling proteins through the scaffold protein PSD-95. As potential roles
for integrins in modifying NMDAR activity have also been shown we
have now investigated the relationship between NMDAR signaling in
chondrocytes and molecules that are involved in chondrocyte mechan-
otransduction.
Methods: Articular cartilage was removed from OA and chondrocytes
released using sequential enzymatic digestion. Chondrocytes were main-
tained as non-conﬂuent primary monolayer cultures at a concentration
of 5×105 cells/ml. To measure the function of NMDAR cell membrane
potentials of OA cells were measured by electrophysiology in resting
cells, after treatment (integrin modifying or CD47 antibody (1 mg/ml))
and following stimulation with NMDA (50mM). Chondrocytes seeded onto
cell culture dishes coated with substrates (poly-L-lysine or ﬁbronectin;
10mg/ml) were used to assess cell membrane potential before and after
NMDA treatment. Co-immunoprecipitation of PSD-95 with b1 integrin and
CD47 using speciﬁc antibodies was analysed by Western blot.
Results: Incubation of OA chondroctytes with anti-b1 integrin and anti-
CD47 (integrin associated protein) function blocking antibodies inhibited
the electrophysiologcal response to NMDA; antibodies to b3, b5 and
anti-a integrin antibodies had no effect. Integrin dependency of NMDAR
signaling with NMDA treatment was analysed; Chondrocytes adherent
to poly-L-lysine (integrin independent attachment) showed no electro-
physiological response to NMDA while cells adherent to ﬁbronectin and
type II collagen (b1 integrin dependent attachment) showed a membrane
depolarization. Co-immunopreciptiation experiments of PSD-95 with b1
integrin and CD47 identiﬁed that these molecules are physically linked
and therefore may be involved in regulating NMDAR function.
Conclusions: We identify that NMDAR function in chondrocytes is linked
to b1 integrin and CD47, and that the electrophysiological response
to NMDA requires integrin dependent cell-matrix interactions. Linkage
of b1 integrins and CD47 to PSD-95, possibly as part of a complex
that may contain NMDAR, appears to be important in NMDAR activity
in chondrocytes. In neurons studies have shown integrins can be in-
volved in regulating the expression and function of NMDAR, although
the mechanisms by which this occurs have yet to be deﬁned. The role of
NMDAR in OA chondrocyte/cartilage function is yet to be fully understood,
but parallel studies indicate that these receptors may participate in the
signal cascade that results in anabolic/catabolic responses to applied
mechanical forces.
162 CHONDROCYTES FROM OSTEOARTHRITIS PATIENTS
REVERT TO THEIR ORIGIN PHENOTYPE ONCE GROWN
ONTO A HYALURONAN-BASED SCAFFOLD
C. Cavallo1, G. Desando1, L. Cattini1, A. Facchini2, B. Grigolo1. 1Istituto
Ortopedico Rizzoli, Bologna, ITALY , 2Universita` degli Studi di Bologna,
Bologna, ITALY
Purpose: To evaluate the expression of some speciﬁc extracellular matrix
molecules in human chondrocytes from healthy and osteoarthritis carti-
lages freshly isolated and after their growth onto a hyaluronan-based
scaffold used in autologous transplantation procedure.
Methods: Chondrocytes were isolated from human articular cartilage ob-
tained from the knees of patients with osteoarthritis and from multiorgan
donors. First, the cells were expanded in monolayers and then they were
seeded on a hyaluronic-acid derivative scaffold. Constructs were ana-
lyzed at 0, 3, 7, 14, 21 and 28 days after seeding. Immunohistochemical
analysis for collagen type I, II, proteoglycans, Sox-9, MMP-1, MMP-13,
TIMP-1, cathepsin-B was carried out on freshly isolated cells, on cells
grown in monolayer culture and after they were grown onto the scaffold. A
Real-Time RT-PCR analysis was performed on the constructs to evaluate
the expression of the speciﬁc genes at the different experimental times
evaluated.
Results: Chondrocytes freshly isolated from control and OA patient
cartilages expressed the same extracellular matrix molecules even if
at different amount. These differences, which were appreciable both at
protein and molecular levels, were not evident once the cells were grown
onto Hyaff®-11 scaffold. In this experimental culture condition the cells
derived from control and OA patients showed a signiﬁcative increase of
collagen type II, Sox-9 and aggrecan and a decrease of collagen type I
compared to chondrocytes grown in monolayer. On the other hand, MMPs
were downregulated in both the cell types evaluated by the speciﬁc action
of TIMP-1 which was highly expressed at molecular and protein levels in
the two groups.
Conclusions: The growth of chondrocytes onto Hyaff®-11 membrane
seems to erase the differences between the cells derived from normal
and OA cartilages. The hyaluronan-based scaffold is able to recapitulate
some embryonic events which allow to the expression of the extracellular
matrix speciﬁc genes and to the production of the appropriate proteins.
This is of particular relevance hypothesizing the use of tissue engineering
therapeutical approach also in osteoarthritis patients.
163 RELATIONSHIP BETWEEN INSULIN-LIKE GROWTH
FACTOR-1 RECEPTOR EXPRESSION AND MICROSCOPIC
SCORE IN NORMAL EQUINE JOINTS
J.M. Dunleavy, M. Sharif, C.J. Fuller. University of Bristol, Bristol,
UNITED KINGDOM
Purpose: Osteoarthritis (OA) is a chronic degenerative disease of the
articular cartilage which appears to reﬂect a failure in the attempted repair
of the cartilage. Comprehensive data regarding the biological nature of
both normal and early OA tissue are lacking. Until such data are available,
accurate comparison of variables between cartilage from different joints
and potential therapeutic strategies may be compromised. Insulin-like
growth factor-1 (IGF-1) is a potential therapeutic agent in OA due to its
potent anabolic effect in normal cartilage. In an OA joint, chondrocytes are
phenotypically disturbed, and demonstrate altered receptor expression.
Disruption in levels of IGF-1 and expression of its receptor (IGF-1R)
causes enhanced catabolism of proteoglycans. Therefore the aim of the
current study was to investigate IGF-1R expression in macroscopically
normal cartilage from grossly normal joints and correlate this with micro-
scopic score, in an attempt to further understand the normal condition of
cartilage.
Methods: Macroscopically normal cartilage from grossly normal joints
was sampled from six sites on the mediodistal metacarpal condyle
at distances from the transverse ridge (dashed line in ﬁgure 1) of
